Modulation of cytokine production and silica-induced lung fibrosis by inhibitors of aminopeptidase N and of dipeptidyl peptidase-IV-related proteases

Life Sciences

Volumn 84, Issue 1-2, 2009, Pages 1-11

  Kühlmann, Ulrike C ^a   Chwieralski, Caroline E ^a   van den Brule, Sybille ^b   Röcken, Christoph ^c   Reinhold, Dirk ^a   Welte, Tobias ^d   Bühling, Frank ^d,e  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e CARL THIEM KLINIKUM   (Germany)

Author keywords

Aminopeptidase; Enzyme; Fibroblast; Inhibitor; Protease

Indexed keywords

ACTINONIN; CHEMOKINE; CYTOKINE; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV RELATED PROTEASE DERIVATIVE; ENZYME INHIBITOR; INTERLEUKIN 6; MICROSOMAL AMINOPEPTIDASE; PROTEINASE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; LUNG ALVEOLUS CELL; LUNG FIBROSIS; LUNG LAVAGE; MONOCYTE; MOUSE; NONHUMAN;

ANIMALS; ANTIGENS, CD13; CELL LINE; CYTOKINES; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HUMANS; HYDROXAMIC ACIDS; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; MICE; MICE, INBRED C57BL; PROTEASE INHIBITORS; PULMONARY FIBROSIS; SILICON DIOXIDE; TRANSFORMING GROWTH FACTOR BETA;

MURINAE;

EID: 57649233540     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.10.001     Document Type: Article

References (58)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). American Journal of Respiratory and Critical Care Medicine 161 (2000) 646-664
2. Abbott C.A., Yazbeck R., Geier M.S., Demuth H.U., and Howarth G.S. Dipeptidyl peptidases and inflammatory bowel disease. Advances in Experimental Medicine and Biology 575 (2006) 155-162
3. Agelli M., and Wahl S.M. Collagen production by fibroblasts. Methods in Enzymology 163 (1988) 642-656
4. Albrecht C., Borm P.J., Adolf B., Timblin C.R., and Mossman B.T. In vitro and in vivo activation of extracellular signal-regulated kinases by coal dusts and quartz silica. Toxicology in Applied Pharmacology 184 (2002) 37-45
5. Ansorge S., Schon E., and Kunz D. Membrane-bound peptidases of lymphocytes: functional implications. Biomedica Biochimica Acta 50 (1991) 799-807
6. Bank U., Heimburg A., Helmuth M., Stefin S., Lendeckel U., Reinhold D., Faust J., Fuchs P., Sens B., Neubert K., Tager M., and Ansorge S. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13) - a novel approach for the treatment of inflammatory bowel disease. International Immunopharmacology 6 (2006) 1925-1934
7. Bank U., Tadje J., Helmuth M., Stefin S., Tager M., Wolke C., Wischeropp A., Ittenson A., Reinhold D., Ansorge S., and Lendeckel U. Dipeptidylpeptidase IV (DPIV) and alanyl-aminopeptidases (AAPs) as a new target complex for treatment of autoimmune and inflammatory diseases-proof of concept in a mouse model of colitis. Advances in Experimental Medicine and Biology 575 (2006) 143-153
8. Barbarin V., Nihoul A., Misson P., Arras M., Delos M., Leclercq I., Lison D., and Huaux F. The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis. Respiratory Research 6 (2005) 112
9. Biondi P.A., Chiesa L.M., Storelli M.R., and Renon P. A new procedure for the specific high-performance liquid chromatographic determination of hydroxyproline. Journal of Chromatographic Science 35 (1997) 509-512
10. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scandinavian Journal of Clinical and Laboratory Investigation Supplement 97 (1968) 77-89
11. Brown J.M., Pfau J.C., and Holian A. Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice. Inhalation Toxicology 16 (2004) 133-139
12. Buhling F., Rocken C., Brasch F., Hartig R., Yasuda Y., Saftig P., Bromme D., and Welte T. Pivotal role of cathepsin K in lung fibrosis. American Journal of Pathology 164 (2004) 2203-2216
13. Buhling F., Tholert G., Kaiser D., Hoffmann B., Reinhold D., Ansorge S., and Welte T. Increased release of transforming growth factor (TGF)-beta1, TGF-beta2, and chemoattractant mediators in pneumonia. Journal of Interferon and Cytokine Research 19 (1999) 271-278
14. Cheng H.C., Abdel-Ghany M., and Pauli B.U. A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. Journal of Biological Chemistry 278 (2003) 24600-24607
15. Dang N.H., Torimoto Y., Sugita K., Daley J.F., Schow P., Prado C., Schlossman S.F., and Morimoto C. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. Journal of Immunology 145 (1990) 3963-3971
16. De Meester I., Korom S., Van Damme J., and Scharpe S. CD26, let it cut or cut it down. Immunology Today 20 (1999) 367-375
17. Eickelberg O., Kohler E., Reichenberger F., Bertschin S., Woodtli T., Erne P., Perruchoud A.P., and Roth M. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. American Journal of Physiology 276 (1999) L814-L824
18. Gerli R., Muscat C., Bertotto A., Bistoni O., Agea E., Tognellini R., Fiorucci G., Cesarotti M., and Bombardieri S. CD26 surface molecule involvement in T cell activation and lymphokine synthesis in rheumatoid and other inflammatory synovitis. Clinical Immunology and Immunopathology 80 (1996) 31-37
19. Gorrell M.D. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clinical Sciences (Lond) 108 (2005) 277-292
20. Gorrell M.D., Gysbers V., and Mccaughan G.W. CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scandinavian Journal of Immunolology 54 (2001) 249-264
21. Hasegawa M., Sato S., and Takehara K. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis. Clinical and Experimental Immunology 117 (1999) 159-165
22. Helene M., Lake-Bullock V., Zhu J., Hao H., Cohen D.A., and Kaplan A.M. T cell independence of bleomycin-induced pulmonary fibrosis. Journal of Leukocyte Biology 65 (1999) 187-195
23. Hopsu-Havu V.K., and Glenner G.G. A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie 7 (1966) 197-201
24. Huaux F., Liu T., Mcgarry B., Ullenbruch M., Xing Z., and Phan S.H. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis. Journal of Immunology 171 (2003) 5470-5481
25. Huaux F., Louahed J., Hudspith B., Meredith C., Delos M., Renauld J.C., and Lison D. Role of interleukin-10 in the lung response to silica in mice. American Journal of Respiratory Cell and Molecular Biology. 18 (1998) 51-59
26. Inoshima I., Kuwano K., Hamada N., Hagimoto N., Yoshimi M., Maeyama T., Takeshita A., Kitamoto S., Egashira K., and Hara N. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. American Journal Physiology and Lung Cell and Molecular Physiology 286 (2004) L1038-1044
27. Juillerat-Jeanneret L., Aubert J.D., and Leuenberger P. Peptidases in human bronchoalveolar lining fluid, macrophages, and epithelial cells: dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme). Journal of Laboratory and Clinical Medicine 130 (1997) 603-614
28. Kahne T., Lendeckel U., Wrenger S., Neubert K., Ansorge S., and Reinhold D. Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review). International Journal of Molecular Medicine 4 (1999) 3-15
29. Kuwano K., Hagimoto N., and Hara N. Molecular mechanisms of pulmonary fibrosis and current treatment. Current Molecular Medicine 1 (2001) 551-573
30. Lambeir A.M., Durinx C., Scharpe S., and De M.I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Critical Review in Clinical Laboratory Sciences 40 (2003) 209-294
31. Lendeckel U., Arndt M., Bukowska A., Tadje J., Wolke C., Kahne T., Neubert K., Faust J., Ittenson A., Ansorge S., and Reinhold D. Synergistic action of DPIV and APN in the regulation of T cell function. Advances in Experimental Medicine and Biology 524 (2003) 123-131
32. Levy M.T., Mccaughan G.W., Marinos G., and Gorrell M.D. Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver 22 (2002) 93-101
33. Lynch J.P., White E., and Flaherty K. Corticosteroids in idiopathic pulmonary fibrosis. Current Opinion in Pulmonary Medicine 7 (2001) 298-308
34. Mcintosh C.H., Demuth H.U., Pospisilik J.A., and Pederson R. Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?. Regulatory Peptides 128 (2005) 159-165
35. Mentlein R. Dipeptidyl-peptidase IV (CD26) - role in the inactivation of regulatory peptides. Regulatory Peptides 85 (1999) 9-24
36. Reinhold D., Bank U., Buhling F., Lendeckel U., Faust J., Neubert K., and Ansorge S. Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells. Immunology 91 (1997) 354-360
37. Reinhold D., Bank U., Buhling F., Neubert K., Mattern T., Ulmer A.J., Flad H.D., and Ansorge S. Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production. Immunobiology 188 (1993) 403-414
38. Reinhold D., Bank U., Buhling F., Tager M., Born I., Faust J., Neubert K., and Ansorge S. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) induces secretion of transforming growth factor-beta 1 (TGF-beta 1) in stimulated mouse splenocytes and thymocytes. Immunology Letters 58 (1997) 29-35
39. Reynolds H.Y. Lung inflammation and fibrosis: an alveolar macrophage-centered perspective from the 1970s to 1980s. American Journal of Respiratory and Critical Care Medicine 171 (2005) 98-102
40. Riemann D., Kehlen A., and Langner J. CD13 - not just a marker in leukemia typing. Immunology Today 20 (1999) 83-88
41. Santos A.N., Langner J., Herrmann M., and Riemann D. Aminopeptidase N/CD13 is directly linked to signal transduction pathways in monocytes. Cellular Immunology 201 (2000) 22-32
42. Schon E., Demuth H.U., Barth A., and Ansorge S. Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes. Biochemical Journal 223 (1984) 255-258
43. Sedo A., Krepela E., Kasafirek E., Kraml J., and Kadlecova L. Dipeptidyl peptidase IV in the human lung and spinocellular lung cancer. Physiological Research 40 (1991) 359-362
44. Steinbrecher A., Reinhold D., Quigley L., Gado A., Tresser N., Izikson L., Born I., Faust J., Neubert K., Martin R., Ansorge S., and Brocke S. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo. Journal of Immunology 166 (2001) 2041-2048
45. Suzuki N., Ohta K., Horiuchi T., Takizawa H., Ueda T., Kuwabara M., Shiga J., and Ito K. T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice. Thorax 51 (1996) 1036-1042
46. Tanaka S., Murakami T., Horikawa H., Sugiura M., Kawashima K., and Sugita T. Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV. International Journal of Immunopharmacology 19 (1997) 15-24
47. Thatcher T.H., Sime P.J., and Barth R.K. Sensitivity to bleomycin-induced lung injury is not moderated by an antigen-limited T-cell repertoire. Experimental Lung Research 31 (2005) 685-700
48. Thielitz A., Bukowska A., Wolke C., Vetter R., Lendeckel U., Wrenger S., Hashimoto Y., Ansorge S., Gollnick H., and Reinhold D. Identification of extra- and intracellular alanyl aminopeptidases as new targets to modulate keratinocyte growth and differentiation. Biochememical and Biophysisical Research Communication 321 (2004) 795-801
49. Thielitz A., Reinhold D., Vetter R., Lendeckel U., Kahne T., Bank U., Helmuth M., Neubert K., Faust J., Hartig R., Wrenger S., Zouboulis C.C., Ansorge S., and Gollnick H. Possible role of DP IV inhibitors in acne therapy. Advances in Experimental Medicine and Biology 575 (2006) 163-167
50. Thielitz A., Ansorge S., Bank U., Tager M., Wrenger S., Gollnick H., and Reinhold D. The ectopeptidase dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases. Frontiers in Biosciences 13 (2008) 2364-2375
51. Torimoto Y., Dang N.H., Vivier E., Tanaka T., Schlossman S.F., and Morimoto C. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. Journal of Immunology 147 (1991) 2514-2517
52. Van Den Brule S., Misson P., Buhling F., Lison D., and Huaux F. Overexpression of cathepsin K during silica-induced lung fibrosis and control by TGF-beta. Respiratory Research 6 (2005) 84
53. Van Der Velden V.H., Wierenga-Wolf A.F., Adriaansen-Soeting P.W., Overbeek S.E., Moller G.M., Hoogsteden H.C., and Versnel M.A. Expression of aminopeptidase N and dipeptidyl peptidase IV in the healthy and asthmatic bronchus. Clinical and Experimental Allergy 28 (1998) 110-120
54. Wahl S.M., Katona I.M., Stadler B.M., Wilder R.L., Helsel W.E., and Wahl L.M. Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). II. Functional properties of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions. Cellular Immunology 85 (1984) 384-395
55. Wahlstrom J., Berlin M., Skold C.M., Wigzell H., Eklund A., and Grunewald J. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 54 (1999) 339-346
56. Williams Y.N., Baba H., Hayashi S., Ikai H., Sugita T., Tanaka S., Miyasaka N., and Kubota T. Dipeptidyl peptidase IV on activated T cells as a target molecule for therapy of rheumatoid arthritis. Clinical and Experimental Immunology 131 (2003) 68-74
57. Wrenger S., Faust J., Friedrich D., Hoffmann T., Hartig R., Lendeckel U., Kahne T., Thielitz A., Neubert K., and Reinhold D. Attractin, a dipeptidyl peptidase IV/CD26-like enzyme, is expressed on human peripheral blood monocytes and potentially influences monocyte function. Journal of Leukocyte Biology 80 (2006) 621-629
58. Zhu Ma B., Zheng T., Homer R.J., Lee C.G., Charo I.F., Noble P., and Elias J.A. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. Journal of Immunology 168 (2002) 2953-2962